课题基金 / 基金详情

Nanoparticle- Infused Radiopaque Absorbable Medical Device

Nanoparticle- Infused Radiopaque Absorbable Medical Device
纳米颗粒注入不透射线可吸收医疗器械
批准号:
10442452
负责人:
Marites Pasuelo Melancon
金额:
$38.63万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-06-30
关键词:
Adverse effectsAdverse eventAdverse reactionsAffectAlgorithmsAmericanAnimalsAnticoagulantsAnticoagulationAutopsyBariumBismuthBlood Circulation TimeBlood VesselsBlood coagulationCalciumCardiovascular DiseasesCardiovascular systemCathetersChronicClinicalCoagulation ProcessComplexContrast MediaDeep Vein ThrombosisDepositionDevelopmentDevicesDisadvantagedDiscriminationDiseaseDoseElectrospinningElementsEmbolismEnhancersEventExcisionExhibitsFailureFatigueFiltrationFluoroscopyFractureGoalsGoldHemorrhageHospitalizationHumanHydrolysisHypersensitivityImageImage EnhancementImaging TechniquesIn VitroInfusion proceduresInterventionIodineLeadLifeLungMechanicsMedical DeviceMetalsMethodsMonitorNail plateOperative Surgical ProceduresOrganOrthopedicsPatientsPharmacologic SubstancePhysiologicalPlaguePolymersPopulationPositioning AttributePreventionProceduresPropertyPublic HealthPulmonary EmbolismReportingResearchRetrievalRiskRodRoentgen RaysSignal TransductionStrokeSurgical suturesSystemTantalumTestingTherapeutic EmbolizationThrombusTimeToxic effectTraumaTungstenVena Cava FiltersVisualizationX-Ray Computed TomographyX-Ray FilmYtterbiumZirconiumabsorptionacute coronary syndromeanimal imagingbiodegradable polymerbiomaterial compatibilitycostcrystallinityexperimental studyflexibilityhigh riskimaging modalityimaging propertiesimaging studyimprovedin vivointerestmathematical algorithmmedical implantmetallicitymortalitynanoparticlenephrotoxicitynovelpoly-4-dioxan-2-oneporcine modelpreventprophylacticradiological imagingroutine imagingsuccesstime usevenous thromboembolismzirconium oxide

项目摘要

项目成果

Marites Pasuelo Melancon的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY Venous thromboembolism (VTE) is the third most common cardiovascular illness after acute coronary syndrome and stroke. The first line of therapy for VTE is blood thinners; however, these agents are temporarily contraindicated for many at-risk VTE patients, such as those with major trauma and those who undergo complex surgeries, for whom bleeding is a concern. Inferior vena cava (IVC) filters are indicated in this population. Most IVC filters (70%) are intended to be retrieved after their indicated use; however, only 19%- 30% are removed. Unfortunately, complications mount when IVC filters are not removed, which can be very costly ($3,000-$12,000 for filter retrieval and ~$67,000 for treatment of complications). Therefore, resorbable IVC filters were developed, which provide critical protection during their required duration and then simply vanish from the body, thereby alleviating costly removal procedures and downstream complications. However, an important limitation of a resorbable IVC filter system is significant clot burden. Monitoring the absorption time and any significant clot burden with use of imaging techniques would greatly improve the efficacy of deep vein thrombosis treatment. In this study, we will develop of radiopaque absorbable filters that can be routinely imaged to offer a less expensive alternative to assessing filter integrity. Moreover, visualization of the filter under dual-energy computed tomography (DECT) would facilitate discrimination between two or more materials, such as nanoparticles (NPs), iodine, and calcium deposits, which could provide better image quality and quantification of the materials present in the filter. Specifically, we propose to incorporate NPs (made up of gold, bismuth, ytterbium, tantalum, tungsten, barium, and zirconium), into clinically available resorbable polydioxanone (PPDO) suture, investigate the effect of NP infusion within PPDO sutures in terms of mechanical strength, toxicity, and physico-chemical properties over a period of 10 weeks when subjected to human physiological conditions, and perform large animal imaging study using optimized DECT parameters to determine radiopacity, toxicity, and mechanical strength, as well as adverse reactions of image-enhanced suture during necropsies. We will also develop a mathematical algorithm for DECT for the quantification of the different high atomic (Z) number contrast materials infused within the PPDO. Our long-term goal is to develop a totally absorbable IVC filter, inexpensively deployed and monitored by conventional imaging methods that prevents pulmonary embolism for the recommended prophylactic period and then simply vanishes without intervention. The experiments outlined here will be critical to demonstrating the feasibility of using NPs as radiopaque material for DECT imaging embedded within this medical device. Successful development of imaging enhancers for IVC filters may also lead to widespread use of absorbable devices in other cardiovascular and orthopedic applications in which fixtures (such as plates, screws, nails, and rods) are needed only on a temporary basis.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/molecules26020384
发表时间: 2021-01-13
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者: [Hagaman DE, Damasco JA, Perez JVD, Rojo RD, Melancon MP]
通讯作者: Melancon MP
DOI: 10.1080/10717544.2020.1869863
发表时间: 2021-12
期刊: Drug delivery
影响因子: 6
作者: [Melancon MP, Yevich S, Avritscher R, Swigost A, Lu L, Tian L, Damasco JA, Dixon K, Cortes AC, Munoz NM, Liang D, Liu D, Tam AL]
通讯作者: Tam AL
DOI: 10.3390/biom12101367
发表时间: 2022-09-24
期刊: Biomolecules
影响因子: 5.5
作者: []
通讯作者:
DOI: 10.21037/tcr.2017.03.53
发表时间: 2017-03
期刊: Translational cancer research
影响因子: 0.9
作者: [Tian L, Chang A, Melancon MP]
通讯作者: Melancon MP
10
    Biodegradable Radiopaque Polymeric Scaffolds Loaded with Mesenchymal Stem Cells for Image-Guided Arteriovenous Fistula Maturation and Long-Term Patency
    Biodegradable Radiopaque Polymeric Scaffolds Loaded with Mesenchymal Stem Cells for Image-Guided Arteriovenous Fistula Maturation and Long-Term Patency
    Nanoparticle- Infused Radiopaque Absorbable Medical Device
    Nanoparticle-Infused Radiopaque Absorbable Medical Device
    海外基金